In a recent study, researchers at the University of Zurich and the University of Oxford developed a new artificial intelligence (AI) tool to determine DNA mismatch repair (MMR) status in colorectal cancer. The tool achieved 98% accuracy in identifying MMR deficiency across two large clinical trial cohorts of patients with colorectal cancer and could reduce pathologist workload by correctly classifying over three-quarters of cases without human review.
AI-Powered Analysis of Routine Pathology Samples Achieves 98% Accuracy in Detecting DNA Mismatch Repair Deficiency in Colorectal Cancer (Pathology News)
0